| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |